GE HealthCare Technologies SG&A increased by 0.5% to $1.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.4%, from $1.04B to $1.12B. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 4.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
Metric ID:
selling_general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $890.75M | $890.75M | $890.75M | $931.00M | $908.00M | $908.00M | $884.00M | $1.06B | $1.07B | $996.00M | $1.15B | $1.04B | $1.07B | $1.03B | $1.13B | $1.04B | $1.03B | $1.05B | $1.11B | $1.12B |
| QoQ Change | — | +0.0% | +0.0% | +4.5% | -2.5% | +0.0% | -2.6% | +20.1% | +0.9% | -7.1% | +15.7% | -9.9% | +2.8% | -3.1% | +9.3% | -8.0% | -1.1% | +1.6% | +6.3% | +0.5% |
| YoY Change | — | — | — | — | +1.9% | +1.9% | -0.8% | +14.1% | +18.1% | +9.7% | +30.3% | -2.3% | -0.5% | +3.8% | -1.9% | +0.2% | -3.6% | +1.1% | -1.7% | +7.4% |
Range$884.00M – $1.15B
CAGR+4.9%
Avg YoY Growth+4.9%
Median YoY Growth+1.5%
Current Streak3 quarters growth
SG&A at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's sg&a?
- GE HealthCare Technologies (GEHC) reported sg&a of $1.12B in Q1 2026.
- How has GE HealthCare Technologies's sg&a changed year-over-year?
- GE HealthCare Technologies's sg&a increased by 7.4% year-over-year, from $1.04B to $1.12B.
- What is the long-term trend for GE HealthCare Technologies's sg&a?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's sg&a has grown at a 4.4% compound annual growth rate (CAGR), from $3.56B to $4.23B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.